Related Experiment Video
Updated: Mar 2, 2026

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
Assesment effectiveness of treatment Eustachian tube dysfunction using pneumatic inhaler AMSA
Insights
Inhaler AMSA treatment significantly improved Eustachian tube dysfunction and conductive hearing loss in children more quickly than traditional pharmacotherapy.
Area of Science:
- Otolaryngology
- Pediatric Medicine
- Audiology
Background:
- Upper respiratory tract infections are common in children, increasing susceptibility to middle ear infections.
- Children's Eustachian tube anatomy predisposes them to impaired patency and conductive hearing loss.
- Eustachian tube dysfunction is a frequent complication of pediatric upper respiratory infections.
Purpose of the Study:
- To assess the effectiveness of the AMSA inhaler for treating Eustachian tube dysfunction.
- To compare AMSA inhaler treatment with conventional pharmacotherapy for Eustachian tube dysfunction.
- To evaluate the impact of AMSA inhaler on conductive hearing loss associated with Eustachian tube dysfunction.
Main Methods:
- A study group of 30 patients with conductive hearing loss was treated with the AMSA inhaler.
- A control group of 30 patients received pharmacological treatment for Eustachian tube dysfunction.
- Pure-tone audiometry and impedance testing were conducted at baseline, 1 week, and 4 weeks.
Main Results:
- Patients treated with the AMSA inhaler showed statistically significant improvement in studied parameters.
- Improvement in Eustachian tube dysfunction and hearing parameters occurred faster with AMSA inhaler treatment.
- AMSA inhaler therapy demonstrated superior efficacy compared to pharmacotherapy in a shorter timeframe.
Conclusions:
- The AMSA inhaler is an effective treatment for Eustachian tube dysfunction in children.
- AMSA inhaler treatment offers a faster resolution of conductive hearing loss compared to pharmacotherapy.
- This study supports the use of AMSA inhaler as a beneficial therapeutic option for pediatric Eustachian tube dysfunction.
Introduction:
Upper respiratory tract infections are common childhood diseases. Children are more susceptible to middle ear infections because their Eustachian tube is short, straight and wide. As a consequence of these inflammatory changes while impaired patency of the Eustachian tube often arises conductive hearing.
Objective:
The aim of this study was to Assessment effectiveness of treatment Eustachian tube dysfunction using inhaler AMSA.
Material And Methods:
The study group comprised 30 patients. Same was in the control group. All patients reported conductive hearing loss. Test group was treated as an inhaler AMSA. The control group was treated pharmacologically. Patients were examined with the use of pure-tone audiometry, and impedance at baseline, after one week and four weeks.
Results:
Statistical analysis showed improvement in the studied parameters in patients treated with inhaler AMSA in a much shorter time than patients treated with pharmacotherapy.
Related Concept Videos
Physical Assessment of the Respiratory Tract IV: Auscultation
Breath Sounds
Breath sounds are categorized into vesicular, bronchovesicular, and bronchial.
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

